Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Mar;47(2):101178.
doi: 10.1016/j.diabet.2020.07.005. Epub 2020 Jul 29.

Body mass index and outcome in patients with COVID-19: A dose-response meta-analysis

R Pranata  1 , M A Lim  2 , E Yonas  3 , R Vania  2 , A A Lukito  4 , B B Siswanto  5 , M Meyer  6
Affiliations
Meta-Analysis

Body mass index and outcome in patients with COVID-19: A dose-response meta-analysis

R Pranata et al. Diabetes Metab. 2021 Mar.

Abstract

Background: There is mounting evidence related to the association between obesity and severity of COVID-19. However, the direct relationship of the increase in the severe COVID-19 risk factors, with an increase in body mass index (BMI), has not yet been evaluated.

Aim: This meta-analysis aims to evaluate the dose-response relationship between body mass index (BMI) and poor outcome in patients with COVID-19.

Methods: A systematic literature search was conducted using PubMed, Europe PMC, ProQuest, and the Cochrane Central Database. The primary outcome was composite poor outcome composed of mortality and severity. The secondary outcomes were mortality and severity.

Results: A total of 34,390 patients from 12 studies were included in this meta-analysis. The meta-analysis demonstrated that obesity was associated with composite poor outcome (OR 1.73 [1.40, 2.14], P<0.001; I2: 55.6%), mortality (OR 1.55 [1.16, 2.06], P=0.003; I2: 74.4%), and severity (OR 1.90 [1.45, 2.48], P<0.001; I2: 5.2%) in patients with COVID-19. A pooled analysis of highest BMI versus reference BMI indicate that a higher BMI in the patients was associated with composite poor outcome (aOR 3.02 [1.82, 5.00], P<0.001; I2: 59.8%), mortality (aOR 2.85 [1.17, 6.92], P=0.002; I2: 79.7%), and severity (aOR 3.08 [1.78, 5.33], P<0.001; I2: 11.7%). The dose-response meta-analysis showed an increased risk of composite poor outcome by aOR of 1.052 [1.028, 1.077], P<0.001 for every 5kg/m2 increase in BMI (Pnon-linearity<0.001). The curve became steeper with increasing BMI.

Conclusion: Dose-response meta-analysis demonstrated that increased BMI was associated with increased poor outcome in patients with COVID-19.

Keywords: Body mass index; Coronavirus; Obesity; SARS-CoV-2; Weight.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Study flow diagram.
Fig. 2
Fig. 2
Obesity and poor outcome. Forest-plot showing the association between obesity and composite poor outcome (A), mortality (B), and severity (C). 95% CI: 95% confidence interval, I-squared: I2.
Fig. 3
Fig. 3
Body mass index and poor outcome. Forest-plot showing the association between body mass index and composite poor outcome (A), mortality (B), and severity (C). 95% CI: 95% confidence interval, I-squared: I2.
Fig. 4
Fig. 4
Dose response meta-analysis between body mass index and composite poor outcome in patients with COVID-19 with restricted cubic splines in a multivariate random-effects dose–response model. Adjusted odds ratio (solid line) with 95% confidence interval (long dashed lines) for the association of the body mass index level with the risk of composite poor outcome.
Fig. 5
Fig. 5
Funnel-plot analysis for obesity and composite poor outcome.
See this image and copyright information in PMC

References

    1. World Health Organization . 2020. Coronavirus disease (COVID-19) situation report – 164. Geneva.
    1. Huang I., Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care. 2020;8:36. doi: 10.1186/s40560-020-00453-4. - DOI - PMC - PubMed
    1. Klang E., Kassim G., Soffer S., Freeman R., Levin M.A., Reich D.L. Morbid obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50. Obesity. 2020 doi: 10.1002/oby.22913. oby.22913. - DOI - PMC - PubMed
    1. Giacomelli A., Ridolfo A.L., Milazzo L., Oreni L., Bernacchia D., Siano M. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study. Pharmacol Res. 2020:104931. doi: 10.1016/j.phrs.2020.104931. - DOI - PMC - PubMed
    1. Palaiodimos L., Kokkinidis D.G., Li W., Karamanis D., Ognibene J., Arora S. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. doi: 10.1016/j.metabol.2020.154262. - DOI - PMC - PubMed

Publication types